<DOC>
	<DOCNO>NCT02137395</DOCNO>
	<brief_summary>The purpose study determine whether dexamethasone extend duration recovery anesthesia .</brief_summary>
	<brief_title>The Effect Dexamethasone Sugammadex Reversal</brief_title>
	<detailed_description>After obtain Local Ethics Committee Cukurova University approval write parental consent , prospective , randomize , double blind , placebo-controlled study perform . Sixty patient schedule elective tonsillectomy adenoidectomy , age 3-8 year American Society Anesthesiologists physical status 1 2 recruit study . Exclusion criterion presence respiratory , hepatic , renal cardiovascular disease , oropharyngeal facial pathology , neuromuscular disorder , hypertension diabetes mellitus . Patients randomly allocate two group 1:1 ratio computer-generated list . Allocation provide seal envelope contain group name paper . Patients admit preoperative unit 30 minute operation . All patient monitor non-invasive blood pressure ( NIBP ) , electrocardiogram ( ECG ) , end-tidal carbon dioxide ( ETCO2 ) peripheral oxygen saturation ( SpO2 ) operating room start anesthesia induction . Anesthesia induce 4-5 % sevoflurane cannula ( 18 gauge ) place intravenously ensure adequate depth anesthesia thus 0.9 % saline infusion start 10 mL kg-1 hr-1 rate hydration . Patients receive dexamethasone via intravenous ( iv ) route 0.5 mg.kg-1 ( maximum dose 15 mg ) equal volume saline iv , group D group S , respectively . Neuromuscular monitoring initiate induction anesthesia acceleromyograph ( TOF-Watch® S ; Organon Ireland Ltd , Drynam Road , Swords , Co. Dublin , Ireland ) measure function adductor pollicis muscle . A transducer attach thumb . Two electrode place cleaned skin correspond ulnar nerve trajectory wrist . Stabilization calibration perform TOF-Watch S accord good clinical research practice pharmacodynamic study NMBAs . ( Fuchs-Buder , Claudius et al . 2007 ) After calibration , Train Four stimulation ( TOF ) apply repetitively every 15 minute 3 minute . Rocuronium administer intravenously dose 0.6 mg.kg-1 followed calibration period . Tracheal intubation perform obtain adequate neuromuscular blockade . TOF stimulation maintain every 15 minute end anesthesia , TOF ratio 0.9 . SpO2 , ECG NIBP monitor 10 minute interval neuromuscular data obtain TOF-Watch® S record . When T2 TOF reappear , patient administer single bolus injection sugammadex dose 2 mg.kg-1 . The time achieve TOF ratio 0.9 sugammadex administration record patient . At end surgery anesthesia terminate awake patient extubated . After extubation , patient transport postoperative care unit . Pulse oximetry , respiratory rate non-invasive blood pressure monitoring , level consciousness clinical evaluation recovery ( 5 head lift test , absence diplopia , tongue depressor test , general muscle weakness ) record 15 minute interval 60 minute postanesthesia care unit ( PACU ) . Any adverse effect record surgery postoperatively 10 hour . All record drug administration perform anesthetist , blind patient group . The primary endpoint define time achieve TOF ratio 0.9 sugammadex administration .</detailed_description>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>patient schedule elective tonsillectomy adenoidectomy , age 38 year American Society Anesthesiologists physical status 1 2 presence respiratory , hepatic , renal cardiovascular disease , oropharyngeal facial pathology neuromuscular disorder hypertension diabetes mellitus .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Children , Dexamethasone , Sugammadex ,</keyword>
</DOC>